NeuroVision Acquires Durin Life Sciences to Advance Earlier Detection and Management of Neurodegenerative Disease

NeuroVision Acquires Durin Life Sciences to Expand Neurodegenerative Disease Diagnostics Platform

Key Takeaways NeuroVision Imaging acquired Durin Life Sciences to combine blood-based biomarker diagnostics with retinal imaging, telehealth, and patient engagement technologies for neurodegenerative disease care The combined company plans to expand development and commercialization of diagnostic tools for Alzheimer’s disease, Parkinson’s disease, ALS, and related neurological disorders NeuroVision Imaging announced it has acquired Durin Life …

NeuroVision Acquires Durin Life Sciences for Neurodegenerative Disease Diagnostics

The acquisition combines blood-based biomarker tests with retinal imaging and telehealth to support early detection of Alzheimer’s and Parkinson’s diseases. NeuroVision Imaging Inc announced the acquisition of Durin Life Sciences Inc to create an integrated diagnostics and care platform for neurodegenerative diseases. The deal aims to improve early detection, patient access, and long-term brain health management, according to a company release. …

NeuroVision Acquires Durin Life Sciences to Advance Earlier Detection and Management of Neurodegenerative Disease

Combined company brings together blood-based diagnostics, retinal imaging, and a national patient-facing telehealth platform to support earlier intervention and longitudinal careSACRAMENTO, Calif.--(BUSINESS WIRE)--NeuroVision Imaging Inc. today announced the acquisition of Durin Life Sciences Inc., creating an integrated neurodegenerative disease diagnostics and care platform focused on advancing earlier detection, patient access, and longitudi…